Female Sexual Dysfunction: Focus on Low Desire

  title={Female Sexual Dysfunction: Focus on Low Desire},
  author={Sheryl A Kingsberg and Terri L. Woodard},
  journal={Obstetrics \& Gynecology},
Low or absent sexual desire is the most common sexual dysfunction in women, and its prevalence peaks during midlife. Its etiology is complex and may include biologic, psychologic, and social elements. Major risk factors for its development include poor health status, depression, certain medications, dissatisfaction with partner relationship, and history of physical abuse, sexual abuse, or both. Diagnosis is based on criteria set by the Diagnostic and Statistical Manual of Mental Disorders (5th… 
Evaluation and Management of Hypoactive Sexual Desire Disorder
Low Sexual Desire Disorder
The aim of this chapter is to help health-care professionals understand low sexual desire disorder (“LSDD”), assess for problems of sexual desire, and implement empirically supported interventions for LSDD.
Assessment and management of sexual dysfunction in the context of depression
A concise, evidence-based schematic is presented to assist physicians in minimizing treatment-emergent sexual dysfunction (TESD) while treating depression.
Flibanserin and Female Sexual Desire.
Female sexual dysfunction and Escitalopram antidepressant
Depression is major risk factor for sexual dysfunction (SD),and vice versa. Relative to men, women are at increased risk for depression and anxiety, as well as increased risk of SD. Depression may
Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women
Being dissatisfied with BI is a determinant factor of HSDD that is more probable in the people with negative image of their body structure and feeling lack of bodily appeal, thus it is imperative to pay attention to this factor when analyzing H SDD.
The complicated etiology of hypoactive sexual desire disorder often needs multidimensional intervention to use biopsychosocial approach and multi factor assessment with a combination of psychological, physical, social and hormonal intervention can be effective in making strategies to treat the symptoms of HSDD.
Female Sexual Dysfunction: Assessment and Treatment
  • H. Dahlen
  • Psychology, Medicine
    Urologic Nursing
  • 2019
Since women with urogenital signs and symptoms seek urological services, it is essential for urologic nurses and associates to familiarize themselves with how to empower women with FSD.
A Model for the Management of Female Sexual Dysfunctions.
A protocol used to assess women's sexual problems and the teaching, orienting and permitting (TOP) intervention model that was designed to guide gynecologists in the management of sexual complaints are presented.
Female sexual dysfunction and associated co-morbidities: a cross sectional study with Female Sexual Function Index (FSFI) in a tertiary care hospital of Bangladesh
Female Sexual Dysfunction occurs when a woman is unable to fully experience pleasure during sexual activity that causes distress, affects a woman’s quality of life, lead to interpersonal relationship impairments.


Hypoactive sexual desire in women
Low sexual desire is the most prevalent sexual problem in women and should be assessed and treated by healthcare professionals, and there are only modest evidence-based nonpharmacologic treatment options and no approved pharmacologic options.
Managing female sexual dysfunction.
  • J. Buster
  • Psychology
    Fertility and sterility
  • 2013
Women's sexual desire and arousal disorders.
Specific recommendations for the assessment and treatment of women's desire, arousal, and orgasm disorders are forwarded; however, more research into these domains is needed.
Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)
HSDD is prevalent among women at all reproductive stages, with younger surgically postmenopausal women at greater risk, and is associated with a less active sex life and decreased sexual and relationship satisfaction.
Inhibited sexual desire in women
A multifaceted study was conducted to identify differences in biopsychosocial characteristics between a clinical group of 59 married women who complained of inhibited sexual desire (ISD) and 31
Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden.
Women with HSDD showed more HRQOL impairment than healthy population norms but were similar to adults with other chronic conditions such as diabetes and back pain.
Standard operating procedures for taking a sexual history.
A standard operating procedure (SOP) for taking a sexual history from men or women with sexual problems or performance concerns is presented and offers HCPs a brief, structured, and uniform method.
Efficacy of psychosocial interventions in men and women with sexual dysfunctions--a systematic review of controlled clinical trials: part 2--the efficacy of psychosocial interventions for female sexual dysfunction.
Traditional sexual therapeutic concepts proved to be efficacious in the treatment of female sexual dysfunction.
Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
Prevalence of low sexual desire is elevated among surgically and naturally menopausal women vs premenopausal women, and distress about low desire appears to be more than twice as prevalent among surgery-bound women vs women in stable relationships, although the estimate is fairly imprecise.